10.50
1.16%
0.12
Precedente Chiudi:
$10.38
Aprire:
$10.52
Volume 24 ore:
9,367
Relative Volume:
0.22
Capitalizzazione di mercato:
$392.24M
Reddito:
$4.71M
Utile/perdita netta:
$-46.77M
Rapporto P/E:
-6.253
EPS:
-1.6792
Flusso di cassa netto:
$-60.34M
1 W Prestazione:
+1.25%
1M Prestazione:
+31.25%
6M Prestazione:
+26.81%
1 anno Prestazione:
+28.99%
Nyxoah Sa Stock (NYXH) Company Profile
Nome
Nyxoah Sa
Settore
Industria
Telefono
-
Indirizzo
-
Confronta NYXH con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
NYXH
Nyxoah Sa
|
10.50 | 392.24M | 4.71M | -46.77M | -60.34M | -1.6792 |
ISRG
Intuitive Surgical Inc
|
580.18 | 207.17B | 8.35B | 2.32B | 586.00M | 6.41 |
BDX
Becton Dickinson Co
|
248.49 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
ALC
Alcon Inc
|
92.32 | 45.82B | 9.76B | 1.16B | 665.00M | 2.34 |
RMD
Resmed Inc
|
257.65 | 38.09B | 4.81B | 1.11B | 1.35B | 7.55 |
WST
West Pharmaceutical Services Inc
|
343.91 | 25.10B | 2.88B | 499.60M | 321.60M | 6.74 |
Nyxoah Sa Stock (NYXH) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-07-31 | Iniziato | H.C. Wainwright | Buy |
2023-07-19 | Iniziato | Robert W. Baird | Neutral |
2022-04-21 | Iniziato | Oppenheimer | Outperform |
2022-04-06 | Iniziato | Wolfe Research | Peer Perform |
2021-12-21 | Ripresa | Cantor Fitzgerald | Overweight |
2021-07-28 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Nyxoah Sa Borsa (NYXH) Ultime notizie
Trend Tracker for (NYXH) - Stock Traders Daily
Cantor Fitzgerald Predicts Nyxoah FY2025 Earnings - Defense World
NYXHNyxoah SA Ordinary Shares Latest Stock News & Market Updates - StockTitan
Nyxoah Receives Transparency Notification from BlackRock - TipRanks
Publication relating to transparency notifications - GlobeNewswire
BlackRock Reduces Stake in Nyxoah Below 3% Threshold in Latest Holdings Update - StockTitan
Contrasting Nyxoah (NASDAQ:NYXH) and DarioHealth (NASDAQ:DRIO) - Defense World
(NYXH) Proactive Strategies - Stock Traders Daily
Retail investors are Nyxoah S.A.'s (EBR:NYXH) biggest owners and were rewarded after market cap rose by €38m last week - Simply Wall St
Nyxoah (NASDAQ:NYXH) Stock Price Up 1.2% – Here’s What Happened - Defense World
Nyxoah Receives Transparency Notification from BlackRock, Inc. - TipRanks
Nyxoah: The Future Of OSA (NASDAQ:NYXH) - Seeking Alpha
How the (NYXH) price action is used to our Advantage - Stock Traders Daily
BlackRock Takes 3% Stake in Medical Device Maker Nyxoah in Strategic Investment Move - StockTitan
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024 - Finansavisen
(NYXH) Investment Analysis and Advice - Stock Traders Daily
Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles - Investing.com
Nyxoah's SWOT analysis: sleep apnea innovator faces growth hurdles By Investing.com - Investing.com UK
Nyxoah's nerve stimulation device meets endpoints in sleep apnoea studyMedical Device Network - Oficjalny Portal Gminy Brzesko
HC Wainwright Reaffirms “Buy” Rating for Nyxoah (NASDAQ:NYXH) - Defense World
Nyxoah’s Genio Neurostimulator for OSA Launches in England - Sleep Review
Nyxoah's SWOT analysis: sleep apnea innovator's stock poised for US launch - Investing.com
Nyxoah Launches Revolutionary Sleep Apnea Treatment in England with First NHS-Covered Implants - StockTitan
Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in England - GlobeNewswire
Nyxoah Announces Commercial Launch of Genio Innovative Therapy in England - Marketscreener.com
Where are the Opportunities in (NYXH) - Stock Traders Daily
Nyxoah Updates Share Capital and Voting Rights - TipRanks
Information on the Total Number of Voting Rights And Shares: Nyxoah - The Korea Bizwire
Information on the total number of voting rights and shares - GlobeNewswire
Objective long/short (NYXH) Report - Stock Traders Daily
Nyxoah (NASDAQ:NYXH) vs. Alpha Tau Medical (NASDAQ:DRTS) Head to Head Contrast - Defense World
Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare Conference - The Korea Bizwire
Nyxoah to Present at Healthcare Conference Amidst Growth - TipRanks
Nyxoah to Present Sleep Apnea Innovation at Piper Sandler Healthcare Conference | NYXH Stock News - StockTitan
Nyxoah SA (NYXH) Reports Q3 Loss, Tops Revenue Estimates - MSN
Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024: Nyxoah - The Korea Bizwire
Nyxoah Schedules Special Meeting to Vote on EIB Loan Agreement Terms | NYXH Stock News - StockTitan
Publication Relating to Transparency Notifications: Nyxoah - The Korea Bizwire
Nyxoah’s Voting Rights Shift with ResMed Stake - TipRanks
ResMed's Stake in Nyxoah Drops Below 5% Threshold in Latest Holdings Update | NYXH Stock News - StockTitan
Publication relating to transparency notifications, Business Wires News - AsiaOne
Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 17.4% in October - MarketBeat
Nyxoah's SWOT analysis: sleep apnea device maker's stock poised for growth - Investing.com India
Nyxoah Third Quarter 2024 Earnings: €0.50 loss per share (vs €0.27 loss in 3Q 2023) - Simply Wall St
Nyxoah Reports Third Quarter Financial and Operating Results - Wahanariau
Nyxoah sales jump 30% to €1.3 million in Q3 2024 - Medical Buyer
Nyxoah SA Reports Growth Amid Clinical Advances - TipRanks
EQS-News: Nyxoah Reports Third Quarter Financial and Operating Results - sharewise
Nyxoah Eyes Strong US Launch Amid Financial Growth - TipRanks
Nyxoah S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Nyxoah Reports Third Quarter Financial and Operating Results, Business Wires News - AsiaOne
Nyxoah Sa Azioni (NYXH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):